Health Care & Life Sciences » Healthcare Provision | Cryo-Cell International Inc.

Cryo-Cell International Inc. | Income Statement

Fiscal year is December-November. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
18,994.60
20,126.50
21,091.40
23,128.00
25,384.30
29,218.50
Cost of Goods Sold (COGS) incl. D&A
5,510.40
5,803.40
5,723.00
5,929.50
6,856.00
8,719.90
Gross Income
13,484.20
14,323.20
15,368.50
17,198.60
18,528.30
20,498.60
SG&A Expense
11,252.60
11,964.30
12,413.20
14,775.90
13,522.00
15,144.50
EBIT
2,231.60
2,358.90
2,955.20
2,422.70
5,006.20
5,354
Unusual Expense
516.00
409.30
707.60
3,957.90
82.00
192.70
Non Operating Income/Expense
1,364.50
909.50
24.60
2.30
2.10
3.30
Interest Expense
-
-
1,303.90
947.30
1,302.70
1,546.90
Pretax Income
197.00
677.10
949.50
2,480.20
3,623.70
3,617.70
Income Tax
169.60
123.50
7,156.80
1,159.40
1,308.60
4,472.50
Consolidated Net Income
27.40
553.60
8,106.30
1,320.80
2,315.10
854.80
Net Income
27.40
553.60
8,106.30
1,320.80
2,315.10
854.80
Net Income After Extraordinaries
27.40
553.60
8,106.30
1,320.80
2,315.10
854.80
Net Income Available to Common
27.40
553.60
8,106.30
1,320.80
2,315.10
854.80
EPS (Basic)
0.00
0.05
0.83
0.16
0.30
0.11
Basic Shares Outstanding
10,864.60
10,175.80
9,537.60
8,112.80
7,062.90
7,463.10
EPS (Diluted)
0.00
0.05
0.83
0.16
0.30
0.11
Diluted Shares Outstanding
10,972.50
10,429.00
9,795.60
8,112.80
7,653.00
7,463.10
EBITDA
2,626.10
2,735.90
3,196.40
2,709.30
5,236.20
5,671.40
Equity in Affiliates (Pretax)
154.10
362.90
18.80
-
-
-

About Cryo-Cell International

View Profile
Address
700 Brooker Creek Boulevard
Oldsmar Florida 34677
United States
Employees -
Website http://www.cryo-cell.com
Updated 07/08/2019
Cryo-Cell International, Inc. is cord blood bank engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the Cellular Processing and Cryogenic Storage and Prepacyte CB segments. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use.